RootsAnalysis has announced the addition of “Diabetes Monitoring Devices Market, 2020-2030” report to its list ofofferings.
Over time, a number ofcompanies have developed advanced variants of the conventional blood glucosemonitoring devices, which are portable, and minimally / non-invasive. Many suchnext generation solutions have connectivity features that enable patients’health data to be captured and shared with medical professionals, upon request.
In addition, there are anumber of innovative continuous glucose monitoring (CGM) systems, which aredesigned to provide real-time insights on blood glucose levels. Newer variantsof these products have intuitive software that enables patients to quickly makeimportant treatment-related decisions.
KeyMarket Insights
Morethan 240 diabetes monitoring devices are presently available / underdevelopment
Over 80% of the devices arecurrently marketed, while the rest are in under preclinical / clinicalevaluation. It is worth highlighting that majority of the devices mentioned inthe report are self-blood glucose monitors (80%), which are followed by continuousblood glucose monitoring devices (20%).
Over80 companies, across the globe, presently claim to develop diabetes monitoringdevices
Most (46%) of the devicedevelopers are located in North America, primarily in the US; whereas, inEurope, companies involved in the development of disease monitoring solutionsfor diabetics are mostly based in Germany, Switzerland, the UK and France. Itis worth highlighting that around 50% of the industry stakeholders are smallcompanies
Multiplebig pharma players also have significant stake in this field
Top three big pharmaceuticalcompanies are engaged in developing diabetes monitoring device, either in-houseor in partnership with other stakeholders
Partnershipactivity within this domain has grown at a CAGR of 11%, between 2015 and 2019
The maximum number ofpartnerships related to diabetes monitoring devices, were inked in 2019.Majority of the agreements were related to the integration of the products /technologies of the partnering companies, in order to develop an advanced,technically superior offering; these constituted over 50% of the total numberof instances captured in the report.
NorthAmerica and Europe are anticipated to capture over 50% market share, by 2030
In addition, the market inAsia Pacific is projected to capture over 25% market share, by 2030. Further,the current market is driven by revenues generated from the sales ofself-monitoring blood glucose devices (over 79%), which is followedcontributions from continuous glucose monitoring device sales (21%).Considering that type 1 diabetics have a greater need of such diseasemonitoring solutions (owing to the fact that they are on an insulin dependenttreatment regimen), their contributions, in terms of revenues from productsales, are likely to continue to represent the higher market share (94%) in2030.
GetLatest Market Insights:
KeyQuestions Answered
· Who are the leading diabetes monitoringdevice developers?
· What are the popular disease monitoringdevices that are currently available / under development, for diabetics?
· What are the various novel / advancedfeatures being incorporated into diabetes monitoring devices?
· What kind of partnership models are commonlyadopted by stakeholders in this industry?
· What kind of initiatives have been taken bybig pharma companies in this rapidly evolving industry segment?
· What are the factors that are likely toinfluence the evolution of the diabetes monitoring devices market?
· How is the current and future opportunitylikely to be distributed across key market segments?
TheUSD 34 billion (by 2030) financial opportunity within the diabetes monitoringdevices market has been analyzed across the following segments:
Typeof Device
· Self-monitoring Blood Glucose Devices
· Continuous Blood Glucose Monitoring Devices
DiabetesType
· Diabetes Type 1
· Diabetes Type 2
Self-monitoringBlood Glucose Devices
· Lancing Devices
· Blood Glucose Meters
· Testing Strips
ContinuousBlood Glucose Monitoring Devices
· Sensors
· Transmitters
· Receivers
KeyGeographies
· North America
· Europe
· Asia Pacific
· Latin America
· Middle East and North Africa
· Rest of the World
Theresearch includes detailed profiles of key players (listed below) in thisfield, featuring an overview of the company, its technology portfolio, productportfolio, financial information (if available), recent developments and aninformed future outlook.
· APExBIO
· Ascensia Diabetes Care
· i-SENS
· Oak Tree Health
· SD Biosensor
· TaiDoc Technology
· VivaChek Laboratories
Requestfor Customization: https://www.rootsanalysis.com/reports/diabetes-monitoring-devices-market/request-sample.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
You may also beinterested in the following titles:
1. Diabetes Drug DeliveryDevices Market, 2020-2030
2. Non-InvasiveNeurostimulation Devices Market, 2020-2030
3. Human FactorsEngineering and Usability Testing Services Market for Medical Devices,2020-2030
